Panelists discuss how chronic kidney disease leads to iron deficiency anemia through a complex interplay of impaired iron absorption, increased hepcidin production driven by inflammatory cytokines, ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — In the IRONMAN trial, long-term IV iron supplementation in patients with HF and iron deficiency was ...
Please provide your email address to receive an email when new articles are posted on . Anemia is a hallmark complication of advanced chronic kidney disease and of multifactorial origin, including ...
A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in ...
First and only high-dose intravenous iron for iron deficiency anemia of various etiologies SHIRLEY, N.Y.--(BUSINESS WIRE)--American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a ...
None of the IV iron products were found to be associated with an increased risk of adverse or serious adverse events compared with oral iron The safety profiles of various intravenous (IV) iron ...
Intravenous iron shows safe and beneficial outcomes for patients with bacterial infection and anemia
Treatment with intravenous (IV) iron significantly improved survival and increased hemoglobin levels in patients with iron-deficiency anemia who were hospitalized for an acute bacterial infection, ...
AMSTERDAM, the Netherlands—Disappointing many who hoped this large, randomized, double-blind trial would show a clear win, HEART-FID is the latest trial of iron supplementation in heart failure to ...
Intravenous iron associated with significant reduction in 30-day postoperative mortality and morbidity compared with RBC transfusion. HealthDay News — For patients with preoperative iron deficiency ...
Intravenous (IV) iron reduced rehospitalization risk among patients hospitalized with acute heart failure (HF) and low iron, according to research presented at the American Heart Association’s ...
IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate.
Despite decades of iron supplementation programmes, the iron deficiency continues to affect nearly one in two women of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results